Originally published at: Why pharma’s cold chain future may come down to the cube - FreightWaves
As specialty drugs become more expensive and more personalized, one of the pharmaceutical supply chain’s biggest risks remains surprisingly basic: temperature certainty. The industry loses an estimated $35 billion each year to temperature excursions, but according to Ember LifeSciences, the true problem runs deeper than reported losses. Many failures only surface when a patient notices…